Monopar Therapeutics
MNPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645469
In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 3 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Monopar Therapeutics as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +8 vs. Q1 2025
- Shares held
- 3.18M
- +290.5K (+10.1%) vs. Q1 2025
- Total value
- $113.3M
- +$3.93M (+3.6%) vs. Q1 2025
- New holders
- 19
- 15 more added
- Sold out
- 11
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $576.1M |
| Q1 2026 | 82 | $341.5M |
| Q4 2025 | 74 | $360.8M |
| Q3 2025 | 56 | $354.3M |
| Q2 2025 | 43 | $113.3M |
| Q1 2025 | 35 | $109.4M |
| Q4 2024 | 18 | $57.1M |
| Q3 2024 | 6 | $105.9K |
| Q2 2024 | 12 | $310.1K |
| Q1 2024 | 16 | $268.1K |
| Q4 2023 | 14 | $91.7K |
| Q3 2023 | 14 | $182.2K |
| Q2 2023 | 8 | $164.5K |
| Q1 2023 | 11 | $322.9K |
| Q4 2022 | 10 | $471.0K |
| Q3 2022 | 10 | $314.0K |
| Q2 2022 | 13 | $470.6K |
| Q1 2022 | 13 | $519.8K |
| Q4 2021 | 13 | $657.2K |
| Q3 2021 | 9 | $964.4K |
| Q2 2021 | 10 | $1.10M |
| Q1 2021 | 13 | $1.21M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Monopar Therapeutics; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 1,172,368 | $41.6M | 0.02% | +37,962+3.3% | Added |
| Adage Capital Partners GP, L.L.C. | 599,195 | $21.4M | 0.04% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 511,207 | $18.3M | 0.31% | 00.0% | Unchanged |
| BlackRock, Inc. | 205,169 | $7.34M | 0.00% | +190,705+1,318.5% | Added |
| Point72 Asset Management, L.P. | 104,019 | $3.72M | 0.01% | −64,141−38.1% | Reduced |
| ADAR1 Capital Management, LLC | 100,974 | $3.61M | 0.59% | +200+0.2% | Added |
| Geode Capital Management, LLC | 96,919 | $3.47M | 0.00% | +48,379+99.7% | Added |
| Vanguard Group Inc | 86,489 | $3.09M | 0.00% | +31,255+56.6% | Added |
| Affinity Asset Advisors, LLC | 67,500 | $2.42M | 0.36% | +5,500+8.9% | Added |
| State Street Corp | 41,826 | $1.50M | 0.00% | +26,012+164.5% | Added |
| Ally Bridge Group (NY) LLC | 34,537 | $1.24M | 1.03% | +34,537 | New |
| Northern Trust Corp | 31,813 | $1.14M | 0.00% | +22,652+247.3% | Added |
| UBS Group AG | 21,873 | $782.6K | 0.00% | +13,752+169.3% | Added |
| Millennium Management LLC | 14,789 | $529.1K | 0.00% | −45,578−75.5% | Reduced |
| Charles Schwab Investment Management Inc | 13,249 | $474.0K | 0.00% | +13,249 | New |
| Bank of New York Mellon Corp | 8,948 | $320.2K | 0.00% | +8,948 | New |
| Susquehanna International Group, LLP | 8,356 | $299.0K | 0.00% | +8,356 | New |
| Morgan Stanley | 7,932 | $283.8K | 0.00% | +6,508+457.0% | Added |
| Barclays PLC | 7,285 | $260.7K | 0.00% | +7,273+60,608.3% | Added |
| Citadel Advisors LLC | 6,232 | $223.0K | 0.00% | +6,232 | New |
| Rhumbline Advisers | 5,850 | $209.3K | 0.00% | +5,850 | New |
| Gerber, LLC | 5,601 | $200.4K | 0.14% | 00.0% | Unchanged |
| Deutsche Bank AG | 3,385 | $121.1K | 0.00% | +3,385 | New |
| New York State Common Retirement Fund | 2,900 | $103.8K | 0.00% | +2,900 | New |
| MetLife Investment Management | 2,538 | $90.8K | 0.00% | +2,538 | New |
| Wells Fargo & Company | 2,301 | $82.3K | 0.00% | +2,051+820.4% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 2,222 | $79.5K | 0.00% | +2,222 | New |
| Bank of America Corp | 2,109 | $75.5K | 0.00% | −369−14.9% | Reduced |
| JPMorgan Chase & Co | 1,921 | $68.7K | 0.00% | +1,821+1,821.0% | Added |
| Quest Partners LLC | 1,784 | $63.8K | 0.01% | +569+46.8% | Added |
| Citigroup Inc | 1,443 | $51.6K | 0.00% | +1,218+541.3% | Added |
| Police & Firemen's Retirement System of New Jersey | 964 | $34.5K | 0.00% | +964 | New |
| GWM Advisors LLC | 600 | $21.5K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 453 | $16.0K | 0.00% | +453 | New |
| Raymond James Financial Inc | 431 | $15.4K | 0.00% | +431 | New |
| Ameritas Investment Partners, Inc. | 415 | $14.8K | 0.00% | +415 | New |
| BNP Paribas Arbitrage, SA | 347 | $12.4K | 0.00% | +347 | New |
| California State Teachers Retirement System | 254 | $9.09K | 0.00% | +254 | New |
| Amalgamated Bank | 139 | $5.00K | 0.00% | +139 | New |
| Allworth Financial LP | 100 | $3.58K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 31 | $1.11K | 0.00% | +31 | New |
| Royal Bank of Canada | 19 | $1.00K | 0.00% | −186−90.7% | Reduced |
| Sterling Capital Management LLC | 10 | $358 | 0.00% | +10 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −25,988−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −18,480−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,357−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −8,228−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −6,141−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −5,908−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,761−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −16−100.0% | Sold out |